Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127692011 | 12769201 | 1 | I | 201605 | 20160719 | 20160921 | 20160921 | PER | US-ASTRAZENECA-2016SE80145 | ASTRAZENECA | 965.00 | MON | F | Y | 56.20000 | KG | 20160922 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127692011 | 12769201 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160-4.5 MCG., ONE PUFF TWICE A DAY | 3001131C00,3001134C00 | 21929 | |||||||||
| 127692011 | 12769201 | 2 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 127692011 | 12769201 | 3 | C | DONEPEZIL HCL | DONEPEZIL HYDROCHLORIDE | 1 | Oral | 0 | 5 | MG | QD | ||||||||
| 127692011 | 12769201 | 4 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | QD | ||||||||
| 127692011 | 12769201 | 5 | C | DIPHENHYDRAMINE. | DIPHENHYDRAMINE | 1 | Oral | 0 | 25 | MG | QD | ||||||||
| 127692011 | 12769201 | 6 | C | DIPHENHYDRAMINE. | DIPHENHYDRAMINE | 1 | Oral | 0 | 25 | MG | QD | ||||||||
| 127692011 | 12769201 | 7 | C | CENTRUM SILVER | MINERALSVITAMINS | 1 | Oral | 1, DAILY | 0 | TABLET | |||||||||
| 127692011 | 12769201 | 8 | C | MUCINEX | GUAIFENESIN | 1 | 0 | 600 | MG | BID | |||||||||
| 127692011 | 12769201 | 9 | C | MUCINEX | GUAIFENESIN | 1 | 0 | 600 | MG | BID | |||||||||
| 127692011 | 12769201 | 10 | C | CALCIUM | CALCIUM | 1 | Oral | DAILY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127692011 | 12769201 | 1 | Chronic obstructive pulmonary disease |
| 127692011 | 12769201 | 2 | Gastrooesophageal reflux disease |
| 127692011 | 12769201 | 3 | Cerebral disorder |
| 127692011 | 12769201 | 4 | Prophylaxis |
| 127692011 | 12769201 | 5 | Multiple allergies |
| 127692011 | 12769201 | 6 | Nasal congestion |
| 127692011 | 12769201 | 8 | Nasal congestion |
| 127692011 | 12769201 | 9 | Secretion discharge |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127692011 | 12769201 | Cough | |
| 127692011 | 12769201 | Intentional product misuse | |
| 127692011 | 12769201 | Intentional product use issue | |
| 127692011 | 12769201 | Lung disorder | |
| 127692011 | 12769201 | Memory impairment | |
| 127692011 | 12769201 | Multiple allergies | |
| 127692011 | 12769201 | Nasal congestion | |
| 127692011 | 12769201 | Off label use | |
| 127692011 | 12769201 | Product quality issue | |
| 127692011 | 12769201 | Rhinorrhoea | |
| 127692011 | 12769201 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127692011 | 12769201 | 3 | 2016 | 0 | ||
| 127692011 | 12769201 | 10 | 2016 | 0 |